D'ORONZO, STELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.390
EU - Europa 599
AS - Asia 382
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.378
Nazione #
US - Stati Uniti d'America 2.378
SE - Svezia 220
CN - Cina 178
SG - Singapore 120
IT - Italia 92
VN - Vietnam 63
GB - Regno Unito 59
DE - Germania 50
RU - Federazione Russa 48
FI - Finlandia 31
FR - Francia 26
BE - Belgio 19
CA - Canada 11
NL - Olanda 9
AT - Austria 6
IE - Irlanda 6
IL - Israele 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
IN - India 5
AL - Albania 4
DK - Danimarca 3
EE - Estonia 3
CH - Svizzera 2
ES - Italia 2
HU - Ungheria 2
IR - Iran 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
LT - Lituania 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
Totale 3.378
Città #
Fairfield 347
Chandler 315
Nyköping 180
Ashburn 175
Woodbridge 158
Houston 157
Seattle 151
Cambridge 135
Wilmington 120
Ann Arbor 94
Singapore 89
Dong Ket 60
Lawrence 49
Roxbury 46
Beijing 45
New York 39
Nanjing 35
Jacksonville 28
Des Moines 27
Inglewood 23
Brooklyn 22
Helsinki 22
Paris 21
Brussels 19
Bari 18
Los Angeles 18
San Diego 17
Dearborn 14
Princeton 12
Santa Clara 12
Falls Church 11
Boardman 10
London 10
Guangzhou 9
Munich 9
Redwood City 9
Nuremberg 8
Shenyang 8
Jiaxing 7
Tianjin 7
Dublin 6
Nanchang 6
St Albans 6
Tel Aviv 6
Washington 6
Brno 5
Islington 5
Jinan 5
Milan 5
Pune 5
Changsha 4
Chicago 4
Ottawa 4
Vienna 4
West Jordan 4
Xian 4
Amsterdam 3
Edinburgh 3
Rome 3
Tallinn 3
Toronto 3
Acton 2
Auckland 2
Brighton 2
Cancellara 2
Candela 2
Dallas 2
Falkenstein 2
Frankfurt am Main 2
Frederiksberg 2
Grafing 2
Grumo Appula 2
Hanoi 2
Hebei 2
Hefei 2
Kilburn 2
Luoyang 2
Marseille 2
Naples 2
Ningbo 2
Norwalk 2
Prescot 2
Qingdao 2
Shenzhen 2
Stockholm 2
Taizhou 2
Taranto 2
Ardabil 1
Assèmini 1
Athens 1
Atlanta 1
Baku 1
Benxi 1
Bologna 1
Borås 1
Boydton 1
Budapest 1
Buffalo 1
Campi Salentina 1
Catanzaro 1
Totale 2.695
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 219
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 115
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 107
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 105
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 104
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 101
10-year patterns of recurrence from early breast cancer: Analyses of the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 101
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 98
Bone-sialoprotein (BSP), Dickkopf-1 (DKK1) and CXCR4 as potential biomarkers of breast cancer metastasis to bone: Analysis within the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 94
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 93
null 91
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 89
Perspective in infertility: the ovarian stem cells 86
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 86
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 86
The role of biomarkers in the management of bone-homing malignancies 83
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 82
Ddx4+ Oogonial Stem Cells in Postmenopausal Women's Ovaries: A Controversial, Undefined Role 80
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 79
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 78
Cancer Treatment and Bone Health 77
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 77
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 75
Ovarian cancer: Novel molecular aspects for clinical assessment 75
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 72
Breast cancer: an update on treatment-related infertility 71
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 70
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 66
The value of biomarkers in bone metastasis 65
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management 63
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 62
null 61
In vitro generation of oocytes from ovarian stem cells (OSCs): In search of major evidence 61
Bone Metastases; Clinical Aspects 61
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 57
Medical Prevention and Treatment of Bone Metastases. 55
Reply: Improved understanding of very small embryonic-like stem cells in adult mammalian ovary 49
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art 48
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 47
Pulmonary enteric adenocarcinoma: An overview 46
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 39
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 37
[Cell-based strategies: novel perspectives for cancer therapy]. FT Terapie cellulari in oncologia: recenti acquisizioni e sviluppi futuri 36
Bone metastases in hepatocellular carcinoma: an emerging issue 33
null 32
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 31
[Bone health in the oncologic patient]. FT La "bone health" nel paziente oncologico 30
Uterine carcinosarcoma: An overview 30
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 29
Liquid biopsy in cervical cancer: Hopes and pitfalls 28
Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases 26
null 23
The use of bisphosphonates to treat skeletal complications in solid tumours 21
Fertility preservation techniques in cervical carcinoma 16
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations 15
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences 13
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update 11
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view 10
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 10
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 6
Therapeutic approaches to myeloma bone disease: An evolving story 5
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience 4
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 4
Fertility Preservation in the Era of Immuno-Oncology: Lights and Shadows 4
Totale 3.728
Categoria #
all - tutte 20.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 0 0 0 0 0 0 61 69 77 76 68 31
2020/2021807 29 43 50 161 127 69 41 48 36 59 42 102
2021/2022462 24 8 15 13 17 50 13 23 47 54 63 135
2022/2023781 106 124 67 55 74 95 23 79 111 4 26 17
2023/2024348 19 69 23 45 27 88 5 14 7 11 10 30
2024/2025380 35 17 104 65 37 116 6 0 0 0 0 0
Totale 3.728